ArticleCancer medicine2022

KIF11 manipulates SREBP2-dependent mevalonate cross talk to promote tumor progression in pancreatic ductal adenocarcinoma.

Xiang Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.